The Ending Age-Related Diseases 2020 online conference launches today so there will be no regular scheduled news for the next two days as all our staff are busy running the event. There is still time to join us for what promises to be two amazing days of aging research, biotech investment, discussion panels, exclusive interviews, and more!
October 23, 2020
In this panel discussion from Ending Age-Related Diseases 2020, Vadim Gladyshev of Harvard Medical School chairs a panel with Steve Horvath […]
October 22, 2020
A new analysis has revealed a core set of genes involved in aging in both humans and mice. Together with a broader set of age-related genes assembled by the study , this resource will serve as a […]
October 20, 2020
An international collective of scientists has discovered a new cellular process: telomere transfer from antigen-presenting cells to T cells that boosts the latter’s lifespan and proliferative potential . T cells, an important element of our adaptive […]
October 19, 2020
Researchers have successfully used the CRISPR/Cas9 gene editing tool to destroy Ewing’s sarcoma and chronic myeloid leukemia tumor cells by targeting the fusion genes responsible for these tumors . Fusion […]
October 16, 2020
In his presentation at Ending Age-Related Diseases 2020, LEAF board member Javier Noris discussed the Longevity Impact Fund, the reasons why biotechnology funding has been lacking, the "valley of death" that must be crossed in order to fully fund early-stage research through the clinical trial process, and new ways in which venture capital can fund...
October 16, 2020
Insilico Medicine has announced a historic deal with the Taisho Pharmaceutical Company, which is based in Japan, in a partnership to identify and develop new […]